|
"shan y s"的相关文件
显示项目 56-65 / 95 (共10页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 臺大學術典藏 |
2020 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Shen W.-C.; CHIUN HSU; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Hsiao H.-H.; Yang S.-H.; Tsai K.K.; Hsiao C.-F.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2020 |
OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels
|
Chiu, Chiu C.-F.;Weng, J.-R.;Lee, S.-L.;Wu, C.-Y.;Chu, P.-C.;Shan, Y.-S.;Yang, H.-R.;Bai, L.-Y. |
| 國立成功大學 |
2020 |
Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study
|
Hirono, S.;Shimokawa, T.;Nagakawa, Y.;Shyr, Y.-M.;Kawai, M.;Matsumoto, I.;Satoi, Satoi S.;Yoshitomi, H.;Okabayashi, T.;Motoi, F.;Amano, R.;Murakami, Y.;Hirano, S.;Kawamoto, Kawamoto K.;Nakamori, S.;Shan, Y.-S.;Kobayashi, S.;Nitta, H.;Matsukawa, H.;Uchiyama, K.;Hsu, C.-P.;Kitami, C.;Yamamoto, M.;Hwang, T.-L.;Yamaue, H. |
| 國立成功大學 |
2020 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Cancer-derived transforming growth factor-β modulates tumor-associated macrophages in ampullary cancer
|
Cheng, L.-C.;Chao, Y.-J.;Wang, C.-Y.;Phan, N.N.;Chen, Y.-L.;Wang, T.-W.;Hsu, Hsu H.-P.;Lin, Y.-J.;Shan, Y.-S.;Lai, M.-D. |
| 國立成功大學 |
2020 |
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
|
Chen, M.-H.;Chou, W.-C.;Hsiao, C.-F.;Jiang, S.S.;Tsai, H.-J.;Liu, Y.-C.;Hsu, C.;Shan, Y.-S.;Hung, Y.-P.;Hsich, C.-H.;Chiu, Chiu C.-H.;Liu, T.-C.;Cho, S.-F.;Liu, T.-W.;Chao, Y. |
| 國立成功大學 |
2020 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, N.-J.;Tsai, K.K.;Hsiao, C.-F.;Yang, S.-H.;Hsiao, Hsiao H.-H.;Shen, W.-C.;Hsu, C.;Lin, Y.-L.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Loss of EGR-1 uncouples compensatory responses of pancreatic β cells
|
Leu, S.-Y.;Kuo, L.-H.;Weng, Weng W.-T.;Lien, I.-C.;Yang, C.-C.;Hsieh, T.-T.;Cheng, Y.-N.;Chien, P.-H.;Ho, L.-C.;Chen, S.-H.;Shan, Y.-S.;Chen, Y.-W.;Tsai, P.-J.;Sung, J.-M.;Tsai, Y.-S. |
显示项目 56-65 / 95 (共10页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
